Modalis Therapeutics Corporation [4883.T]
TOKYO, Jun 12 (Pulse News Wire) – Modalis Therapeutics Corporation (4883) announced a third-party allotment of stock warrants to EVO FUND. KEY TERMS: - Warrants to be issued: 240,000 - Shares per warrant: 100 - Exercise price: ¥56 - Floor price: ¥28 - Maximum dilution: 24,000,000 shares - Gross proceeds: ¥1.3 billion - Allocation date: 2026-06-12 NOTE: This issuance includes a price adjustment clause ().
The exercise price may be adjusted based on market conditions, which could result in greater dilution than initially indicated. ALLOTTEE: EVO FUND.
🟢 Confidence: High AI-translated content.